Articles

At AAPS PharmSci 360, Xialing Li, PhD, says 3D-printed budesonide tablets achieve precise, delayed delivery to the ileum for IgA nephropathy, lowering in vivo variability.

How 3D-Printed Tablets Can Optimize IgA Nephropathy Treatment

At AAPS PharmSci 360, Xuanzi Zhou says digital twins accurately predict ex vivo lung function, revealing therapeutic effects missed by conventional preclinical drug testing.

AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting

Feliza Mirasol is the science editor for 

Videos

Siddhant Sojitra, Alexion, defines in an AAPS PharmSci 360 2025 presentation an agitation model to reliably test stability for early-stage biologics.

Defining An Agitation Model for Early-Stage, High Concentration Biologics Formulation Development

In a poster presentation at AAPS PharmSci 360, Eda Fenercioglu, a scientist at Pfizer, outlines a streamline workflow for identifying and mitigating visible particles in biologic drugs.

Using A Streamlined Workflow to Identify Particulates in Biologic Drugs

Pharmaceutical Technology® spoke with Steve Lowes, senior director of Scientific Affairs at IQVIA Laboratories, ahead of AAPS PharmSci 360 to discuss some of the unique instruments used to conduct bioanalysis. 

AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Pharmaceutical Technology® spoke with Steve Lowes, senior director of Scientific Affairs at IQVIA Laboratories, ahead of AAPS PharmSci 360 to discuss method validation of biomarker bioanalysis.

Why Context Matters in Validating Biomarker Assays for Bioanalysis

In a poster presentation at AAPS PharmSci 360, by Dineli Ranathunga, PhD, indicates that AI/ML in-silico modeling can accelerate poorly soluble drug development.

Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge

PharmSci 360 will spotlight the economics behind AI, scale-up, and advanced modalities, addressing cost barriers that influence future drug manufacturing.

Why Investment Strategies Matter for Advancing Pharmaceutical Technologies

AI is transforming pharma R&D, bioanalysis, and manufacturing. The industry faces intense competition (obesity wars) and FDA regulatory instability.

PharmTech Weekly News Roundup – Week of November 3, 2025

Pharmaceutical Technology® spoke with Dr. Mark Arnold, owner and principal, Bioanalytical Solution Integration, ahead of AAPS PharmSci 360 to find out how bioanalysis enhances bio/pharmaceutical drug development.